Sirnaomics attracts $25 mln
Gaithersburg, Maryland-based Sirnaomics Inc, a developer of RNAi therapeutics, has raised $25 million in Series C1 financing. Yuexiu New Industrial Investment led the round with participation from Sangel Biomedical Venture Capital, HuaKong Equity Investment and Qianhai Shenghui Investment.
6 June 2018•1 min read
